A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
暂无分享,去创建一个
W. Jędrzejczak | H. Dombret | G. Martinelli | A. Howes | X. Thomas | G. Ossenkoppele | J. Brandwein | T. Robak | J. Harousseau | A. Burnett | T. Masszi | M. Vidriales | J. Maertens | P. De Porre | D. Bordessoule | G. Beutel | Youn-Chan Park | E. Tóthová | A. Golenkov | L. Mollgard | Julia Alexeeva | Nuriet K. Khuageva | Annick Bessems